• Products
  • Company
  • Blog
  • Omixon Academy
  • Support and Resources
  • Contact us
  • Search
  • Request Holotype HLA
  • Request HLA Explore
  • MyHolotype
You can find all our previous LearnMe Videos here. If you do not find what you are looking for please contact support@omixon.com

HLA Twin Videos

  1. Home ›
    2. Omixon Academy ›
  2. HLA Twin Videos
  • Company Videos
  • HLA Twin Videos
  • Lab TrainMe Videos
  • Posters
  • Workshops
  • Symposium
  • Webinars

Welcome to HLA TWIN Learn Me video series!

Explore more about our NGS Data Analysis Software

loading videos

Loading Videos...

Request HLA Explore Free Trial

Omixon Blog

Introduction of HLA Twin v3.0, ABO Typing and Interesting HLA Typing Cases

16/08/2018
Join us for our live product demo and get a guided tour of the features and functionality of HLA Twin...

more

SEE MORE »

Events

BSHI, September 5-6, 2018

16/02/2018

Omixon is attending and having a Lunchtime Workshop at this year’s BSHI Conference in Cardiff, Wales. Register and learn…

more

SEE MORE »

  • Facebook
  • Twitter
Omixon Biocomputing Solutions
Tweets by @OmixonBio

Testimonials

  • “Together with Omixon, we have now used next- generation sequencing tools to significantly advance HLA typing.”Prof. Dimitri Monos, The Children’s Hospital of Philadelphia
  • "It's disappointing sometimes how easily HLA Twin deals with challenging samples like rare alleles. The data is there - you're just convinced!" Alexandre Walencik, Biologiste Médical, Laboratoire HLA - Nantes
  • “We are using next-generation sequencing techniques to advance patient care at Almac and we know that accurate data and meaningful data interpretation are dependent upon employing the best analysis tools and techniques. Omixon was also the strongest performer in terms of total mutations detected with a 99.14% detection sensitivity in single end mode.”Gavin Oliver, Bioinformatics Team Leader at Almac
  • "The Holotype HLA method is optimally designed for the service  laboratory user and is supported by a clear and easily followed protocol which facilitates method performance. Omixon is an enabling and supportive company who work with you to deliver successful outcomes for your programme rather than sales."Brendan Clarke, HLA Lab Director at Leeds St. James's University Hospital
  • “Omixon has developed an excellent direct genotyping method from next generation sequencing that addresses the major problems associated with HLA calling. They have developed industry-leading capabilities that we are very pleased to be able to incorporate into the informatics pipeline that powers our interpretation services offerings.”Wolfgang Daum, CEO of Knome
  • “NGS is rapidly being adopted by clinical and research laboratories worldwide. Easy to use analytical methods and software tools that aid the generation of accurate results are critical for the success of this ground breaking new technology.”Dr Lajos Pusztai,Professor at the University of Texas MD
    Anderson Cancer Center
  • “Best of all, the HLA types reported were fully concordant with data obtained using SBT.”Mike Tayeb, DNA Genotek

 

Omixon Academy

Improve your knowledge!

Our Training Series provide ABHI accredited webinars, workshops, onsite trainings and online demo.

Read more

 

 

Contact Us

Just ask! Get answers!

Your questions and comments are important to us. We’ve got you covered.

Read more

 

 

Omixon Newsletter

Subscribe now!

By clicking 'Ok' I accept the
Privacy Policy

 

Sitemap

Products

  • Holotype HLA
  • HLA Twin
  • HLA Explore
  • Training and Field Support

 

Company

  • About
  • Team
  • Board of Directors
  • Careers / Internships

 

Omixon Academy

  • HLA Library
  • HLA Twin Videos
  • Lab Train Me Videos
  • Posters
  • Workshops
  • Symposiums
  • Webinars
  • Accreditation

 

Contact us

Our Mailing Address:

H-1117 Budapest,
Fehérvári út 50-52.,
Hungary, EU

US Branch Office:

One Broadway,
Cambridge,
MA 02142
USA

Support number: +1 (617) 500 0790

sales@omixon.com | www.omixon.com

 

2012-2018, Omixon Inc. All Rights Reserved.